US 10022347
Compositions and methods for diagnosis and treatment of metabolic syndrome
granted A61KA61K31/20
Quick answer
US patent 10022347 (Compositions and methods for diagnosis and treatment of metabolic syndrome) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/20